Sort
130,381 grants matching “hiv”
Targeted delivery of cytopathicity enhancing agents, and co-ordination with shock and kill, to reduce HIV reservoirs
$838,922R. Brad Jones · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · AI
Comprehensive, tailored, technology-based intervention to improve virologic suppression among youth and young adults living with HIV
$838,883Parya Saberi · University Of California, San Francisco · R01 · FY2025 · MH
The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency
$838,842Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2017 · DA
Using monoclonal antibody Fc variants in strategies to eliminate HIV reservoirs
$838,801Ann Jones Hessell · Oregon Health & Science University · R01 · FY2020 · AI
DRUG ABUSE, HIV, SELENIUM SUPPLEMENTATION, AND CVD RISK
$838,779University Of Miami Coral Gables · R01 · FY2004 · DA
An injectable hydrogel platform for sustained release of eCD4-Ig
$838,771Michael R. Farzan · University Of Florida · R01 · FY2022 · AI
Pharmacogenomics of HIV Therapy
$838,752David W Haas · Vanderbilt University Medical Center · R01 · FY2021 · AI
HIV Reprogrammed Airway Basal Cells Acquire a âTissue Destructiveâ Phenotype
$838,744Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · HL
HIV Reprogrammed Airway Basal Cells Acquire a âTissue Destructiveâ Phenotype
$838,744Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · HL
HIV Reprogrammed Airway Basal Cells Acquire a âTissue Destructiveâ Phenotype
$838,744Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · HL
Preclinical modeling to study Tuberculous Meningitis
$838,739Sanjay Jain · Johns Hopkins University · R56 · FY2019 · AI
A preclinical large animal model for globin gene transfer
$838,713John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
FACULTY TRAINING IN MENTAL HEALTH SERVICES RESEARCH
$838,670University Of California Los Angeles · K12 · FY2000 · MH
MULTICENTER AIDS COHORT STUDY PATHOGENESIS RESEARCH LABS
$838,615University Of California Los Angeles · U01 · FY2002 · AI
Computational and Experimental RNA Nanobiology
$838,605Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Vulnerability to Drug Use & HIV: Advancing Prevention for Rural African Americans
$838,599Gene H Brody · University Of Georgia · P30 · FY2016 · DA
Miami Dade County ASsessment of Phylogenetics to Improve Resource Equity: MD ASPIRE
$838,513Susan Little · University Of California, San Diego · R01 · FY2025 · MH
Evaluating the role of opioid medication assisted therapies in HIV-1 Persistence for persons living with HIV and opioid use disorders
$838,513Sandra Ann Springer · Yale University · R33 · FY2021 · DA
HIV Nef Function and Early Events in Macrophage and Microglia Infection
$838,513Jon W Marsh · National Institute Of Mental Health · Z01 · FY2008 · MH
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine
$838,478Kenneth C Bagley · Profectus Biosciences, Inc. · R44 · FY2017 · AI
HIV-associated Chronic Obstructive Pulmonary Disease
$838,455Mohan L. Sopori · Lovelace Biomedical & Environmental Research Institute · R01 · FY2014 · HL
Early life B cell responses and inflammation following SARS-CoV-2 infection
$838,453Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Clinical Sample Acquisition and Repositorie scientific research support comp
$838,418Myron S Cohen · Duke University · UM1 · FY2012 · AI
Administrative Core
$838,385Richard E Chaisson · Johns Hopkins University · P30 · FY2023 · AI
Correlates of protective immunity to HCV and rational vaccine design: Project 3
$838,357Rama Rao Amara · Emory University · U19 · FY2024 · AI